Cardiac sympathetic afferent reflex and its implications for sympathetic activation in chronic heart failure and...

Area of Science:

• Cardiovascular Physiology
• Neuroscience
• Pathophysiology

Background:

• Persistent sympathetic overactivation is a key factor in chronic heart failure (CHF) and hypertension.
• The cardiac sympathetic afferent reflex (CSAR) is a sympathoexcitatory reflex implicated in these conditions.
• Myocardial ischemia can stimulate cardiac sympathetic afferents, leading to increased sympathetic activity and blood pressure.

Purpose of the Study:

• To review the anatomical and physiological basis of the CSAR.
• To explore the interaction of CSAR with other reflexes like baroreflex and chemoreflex.
• To elucidate the role of enhanced CSAR in the pathogenesis of CHF and hypertension.

Main Methods:

• Review of existing literature on CSAR.
• Analysis of central nervous system pathways involved in CSAR modulation (NTS, PVN, RVLM).
• Investigation of signaling pathways (Angiotensin II, AT1 receptors, NAD(P)H oxidase) in the PVN contributing to enhanced CSAR.

Main Results:

• CSAR is enhanced in conditions like myocardial ischemia, CHF, and hypertension.
• Specific pathways in the PVN, including Angiotensin II and NAD(P)H oxidase, are critical for enhanced CSAR in CHF and hypertension.
• Various signaling molecules regulate CSAR, with central angiotensin-(1-7) and nitric oxide playing key roles.

Conclusions:

• Enhanced CSAR significantly contributes to sympathetic activation in CHF and hypertension.
• Targeting and blocking the CSAR demonstrates positive effects in managing CHF and hypertension.
• Understanding CSAR mechanisms is crucial for developing novel therapeutic strategies for cardiovascular diseases.